Professor Paolo Trevisi, who is featured in this episode of Future Feed Talks, reveals why postbiotics are becoming a promising tool in reducing antibiotic use.
Professor Paolo Trevisi, who is featured in this episode of Future Feed Talks, reveals why postbiotics are becoming a promising tool in reducing antibiotic use.

VIDEO: Why postbiotics matter for early-life piglet growth and gut health

dsm-firmenich
dsm-firmenich Partner profile
02-12-2025 | |
Professor Paolo Trevisi, who is featured in this episode of Future Feed Talks, reveals why postbiotics are becoming a promising tool in reducing antibiotic use.
Professor Paolo Trevisi, who is featured in this episode of Future Feed Talks, reveals why postbiotics are becoming a promising tool in reducing antibiotic use.

We often think of gut health as something we measure later in life, but new research shows that the foundation is laid in the very first days.

In this episode of Future Feed Talks, Professor Paolo Trevisi of the University of Bologna explains how postbiotics given to sows during gestation and lactation can modulate the colostrum metabolome, boost piglet growth and viability, and even support sustainability through the use of fermentation co-products. His latest trial reveals why postbiotics are becoming a promising tool in reducing antibiotic use and strengthening resilience on farm.

This Future Feed Talks episode is a collaboration between dsm-firmenich and Misset International Media.

More about
dsm-firmenich
dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavours, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich  

Related articles
Adult man wearing protective equipment and examining little chick in chicken farm. Photo: Getty images
06-10-2025 | Article

Antibiotic resistance in agriculture: a global wake-up call

dsm-firmenich
dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavours, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich